Works by Selinger, Christian P.


Results: 62
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    18

    Understanding anti‐TNF treatment failure: does serum triiodothyronine‐to‐thyroxine (T3/T4) ratio predict therapeutic outcome to anti‐TNF therapies in biologic‐naïve patients with active luminal Crohn's disease?

    Published in:
    Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 783, doi. 10.1111/apt.17089
    By:
    • Lin, Simeng;
    • Chanchlani, Neil;
    • Carbery, Isabel;
    • Janjua, Malik;
    • Nice, Rachel;
    • McDonald, Timothy J.;
    • Bewshea, Claire;
    • Kennedy, Nicholas A.;
    • Ahmad, Tariq;
    • Selinger, Christian P.;
    • Goodhand, James R.
    Publication type:
    Article
    19

    Inflammatory bowel disease patient‐reported quality assessment should drive service improvement: a national survey of UK IBD units and patients.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 4, p. 625, doi. 10.1111/apt.17042
    By:
    • Hawthorne, A. Barney;
    • Glatter, Jackie;
    • Blackwell, Jonathan;
    • Ainley, Rachel;
    • Arnott, Ian;
    • Barrett, Kevin J.;
    • Bell, Graham;
    • Brookes, Matthew J.;
    • Fletcher, Melissa;
    • Muhammed, Rafeeq;
    • Nevill, Alan M.;
    • Segal, Jonathan;
    • Selinger, Christian P.;
    • St. Clair Jones, Anja;
    • Younge, Lisa;
    • Lamb, Christopher A.;
    • Andrews, Charlie;
    • Barrett, Kevin;
    • Bhatnagar, Gauraang;
    • Bloom, Stuart
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Assessment of steroid use as a key performance indicator in inflammatory bowel disease—analysis of data from 2385 UK patients.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2019, v. 50, n. 9, p. 1009, doi. 10.1111/apt.15497
    By:
    • Selinger, Christian P.;
    • Parkes, Gareth C.;
    • Bassi, Ash;
    • Limdi, Jimmy K.;
    • Ludlow, Helen;
    • Patel, Pritash;
    • Smith, Melissa;
    • Saluke, Santosh;
    • Ndlovu, Zandile;
    • George, Becky;
    • Saunders, John;
    • Adamson, Mark;
    • Fraser, Aileen;
    • Robinson, Jenna;
    • Donovan, Fiona;
    • Parisi, Ioanna;
    • Tidbury, Jude;
    • Gray, Lynn;
    • Pollok, Richard;
    • Scott, Glyn
    Publication type:
    Article
    29
    30
    31

    Safety and tolerability of spesolimab in patients with ulcerative colitis.

    Published in:
    Expert Opinion on Drug Safety, 2023, v. 22, n. 2, p. 141, doi. 10.1080/14740338.2022.2103536
    By:
    • Ferrante, Marc;
    • Irving, Peter M;
    • Selinger, Christian P;
    • D'Haens, Geert;
    • Kuehbacher, Tanja;
    • Seidler, Ursula;
    • Gropper, Savion;
    • Haeufel, Thomas;
    • Forgia, Sebastiano;
    • Danese, Silvio;
    • Klaus, Jochen;
    • Feagan for the spesolimab in UC phase II clinical trial investigators, Brian G.
    Publication type:
    Article
    32
    33
    34
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50